News
A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...
1d
Asian News International on MSNAbu Dhabi Public Health Centre, AstraZeneca forge strategic partnershipUse precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...
Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...
AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug ...
8don MSN
AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...
Explore more
AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending ...
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...
The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...
9d
WBAL-TV on MSNAstraZeneca expansion to turn Maryland facility into one of largest focused on just cell therapyCell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to ...
AstraZeneca aims to widen the pool of bladder cancer patients who can be treated with its PD-L1 inhibitor Imfinzi after the drug demonstrated benefits in those with a higher-risk form of non-muscle | ...
8d
Pharmaceutical Technology on MSNEC approves AstraZeneca’s Calquence combo to treat MCLThe European Commission (EC) has approved AstraZeneca's Bruton's tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results